321 related articles for article (PubMed ID: 21502764)
21. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections.
Saeliw P; Preechawai P; Aui-aree N
J Med Assoc Thai; 2010 Oct; 93(10):1200-4. PubMed ID: 20973324
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of concentrations of botulinum toxin A for the treatment of hemifacial spasm: a randomized double-blind crossover trial.
Li YJ; Huang Y; Ding Q; Gu ZH; Pan XL
Genet Mol Res; 2015 Feb; 14(1):1136-44. PubMed ID: 25730053
[TBL] [Abstract][Full Text] [Related]
23. Treatment of aberrant facial nerve regeneration with botulinum toxin A.
Chua CN; Quhill F; Jones E; Voon LW; Ahad M; Rowson N
Orbit; 2004 Dec; 23(4):213-8. PubMed ID: 15590522
[TBL] [Abstract][Full Text] [Related]
24. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.
Defazio G; Abbruzzese G; Girlanda P; Vacca L; Currà A; De Salvia R; Marchese R; Raineri R; Roselli F; Livrea P; Berardelli A
Arch Neurol; 2002 Mar; 59(3):418-20. PubMed ID: 11890846
[TBL] [Abstract][Full Text] [Related]
26. Trigeminal afferent input alters the excitability of facial motoneurons in hemifacial spasm.
Ogawara K; Kuwabara S; Kamitsukasa I; Mizobuchi K; Misawa S; Hattori T
Neurology; 2004 May; 62(10):1749-52. PubMed ID: 15159472
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
28. A Double-Blind, Placebo-Controlled Study of Appropriate Site of Botulinum Toxin Therapy in Hemifacial Spasm.
Jitpimolmard S; Thinkhamrop B; Tiamkao S; Arunpongpaisal S; Arayavichanon P; Kosuwan W; Jitpimolmard S; Sawanyawisuth K
Adv Ther; 2022 May; 39(5):2025-2034. PubMed ID: 35266085
[TBL] [Abstract][Full Text] [Related]
29. Treatment of hemifacial spasm with botulinum toxin.
Yoshimura DM; Aminoff MJ; Tami TA; Scott AB
Muscle Nerve; 1992 Sep; 15(9):1045-9. PubMed ID: 1518513
[TBL] [Abstract][Full Text] [Related]
30. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment.
Yuksel B; Genc F; Yaman A; Goksu EO; Ak PD; Gomceli YB
Acta Neurol Belg; 2019 Mar; 119(1):55-60. PubMed ID: 30178181
[TBL] [Abstract][Full Text] [Related]
32. An overview of the cosmetic treatment of facial muscles with a new botulinum toxin.
Wiest LG
Acta Dermatovenerol Croat; 2009; 17(1):48-53. PubMed ID: 19386215
[TBL] [Abstract][Full Text] [Related]
33. Childhood-onset hemifacial spasm: successful treatment with botulinum toxin.
Singer C; Papapetropoulos S; Farronay O
Pediatr Neurol; 2005 Sep; 33(3):220-2. PubMed ID: 16139741
[TBL] [Abstract][Full Text] [Related]
34. Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.
Rudzińska M; Wójcik M; Szczudlik A
J Neural Transm (Vienna); 2010 Jun; 117(6):765-72. PubMed ID: 20467763
[TBL] [Abstract][Full Text] [Related]
35. Trigemino-facial inhibitory reflexes in idiopathic hemifacial spasm.
Pavesi G; Cattaneo L; Chierici E; Mancia D
Mov Disord; 2003 May; 18(5):587-92. PubMed ID: 12722175
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
[TBL] [Abstract][Full Text] [Related]
37. Comparison of preseptal and pretarsal onabotulinum toxin an injection in patients with hemifacial spasm.
Yılmaz ATC; Yılmaz M; Öztekin MF
Int J Neurosci; 2021 Jun; 131(6):549-554. PubMed ID: 32233985
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).
Tan EK; Fook-Chong S; Lum SY; Lim E
J Neurol Sci; 2004 Apr; 219(1-2):151-5. PubMed ID: 15050451
[TBL] [Abstract][Full Text] [Related]
39. [The long-term evolution of botulinum toxin dosage in the treatment of hemifacial spasms].
García-Torres MA; García-Ruiz Espiga PJ
Rev Neurol; 2004 Sep 16-30; 39(6):599. PubMed ID: 15468005
[No Abstract] [Full Text] [Related]
40. Intraoperative findings of abnormal muscle response for hemifacial spasm following botulinum neurotoxin treatment.
Nakayama Y; Kawaguchi T; Fukuda M; Oishi M
Acta Neurochir (Wien); 2021 Dec; 163(12):3303-3309. PubMed ID: 34626274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
